New Mountain Finance Corp amended Fifteenth Amendment and Waiver to Loan and Security Agreement with Wells Fargo Bank, National Association (effective 2026-03-12).
“On March 12, 2026, New Mountain Finance Corporation (the “Company”) entered into the Fifteenth Amendment and Waiver to Loan and Security Agreement (the “Fifteenth Amendment”), which amended the Third Amended and Restated Loan and Security Agreement, dated as of October 24, 2017 (together with the exhibits and schedules thereto, the “Loan and Security Agreement”), by and among New Mountain Finance Holdings, L.L.C., as borrower, the Company, as collateral manager, Wells Fargo Bank, National Association (“Wells Fargo”), as administrative agent, and a lender, the lenders party thereto from time to time, and Wells Fargo, as collateral custodian.”
XRNChiron Real Estate Inc.
Chiron Real Estate Inc. amended Sixth Amendment to Agreement of Limited Partnership of Chiron Real Estate LP.
“In connection with the Preferred ATM Offering (as defined below) by Chiron Real Estate Inc. (the “Company”) of the Company’s 8.00% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”), the Agreement of Limited Partnership of Chiron Real Estate LP (the “Operating Partnership”) was amended (the “Amendment”) to provide for the issuance of up to an additional 3,000,000 of the Operating Partnership’s 8.00% Series B Cumulative Redeemable Preferred Units (liquidation preference $25.00 per unit) (the “Series B Preferred Units”).”
WHFWhiteHorse Finance, Inc.
WhiteHorse Finance, Inc. amended Twelfth Amendment with JPMorgan Chase Bank, National Association, as lender and administrative agent, Citibank, N.A., as collateral agent and securities intermediary, Virtus Group LP, as collateral administrator valued at $50,000,000 (effective 2026-03-10).
“On March 10, 2026, WhiteHorse Finance Credit I, LLC (“WhiteHorse Credit”), a wholly owned subsidiary of WhiteHorse Finance, Inc. (the “Company”), entered into a Twelfth Amendment by and among WhiteHorse Credit, as borrower, JPMorgan Chase Bank, National Association, as lender and administrative agent, Citibank, N.A., as collateral agent and securities intermediary, the Company, as portfolio manager, and Virtus Group LP, as collateral administrator (the “Twelfth Amendment”) to amend the terms of the Fifth Amended and Restated Loan Agreement”
CRVSCorvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. entered into Amended and Restated Open Market Sale Agreement with Jefferies LLC valued at maximum aggregate offering price of up to $200,000,000 (effective 2026-03-13).
“On March 13, 2026, the Company entered into an Amended and Restated Open Market Sale Agreement SM (the “Amended Sales Agreement”), with Jefferies LLC (“Jefferies”), to sell shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), from time to time through Jefferies acting as sales agent, having a maximum aggregate offering price of up to $200,000,000.”
FRMMFORUM MARKETS Inc
FORUM MARKETS Inc entered into Warehouse Facility Agreement with Anchored Finance, LLC valued at $10,000,000 (effective 2026-03-05).
“Company”), entered into a Warehouse Facility Agreement, dated as of March 3, 2026 (the “WFA”), with Anchored Finance, LLC, a Connecticut limited liability company (“Anchored Finance”), pursuant to which ETHZilla Auto”
ADTXAditxt, Inc.
Aditxt, Inc. entered into Securities Purchase Agreement with IMAC Holdings, Inc. valued at 36,000 shares of Series A-2 Convertible Preferred Stock ($36,000,000 total stated value) for 100% eq (effective 2026-03-11).
“On March 11, 2026, Aditxt, Inc. (the " Company ") entered into a Securities Purchase Agreement (the " Agreement ") with IMAC Holdings, Inc. (" IMAC ") and the several investors listed on the Schedule of Buyers attached to the Agreement (collectively, the "Buyers") whereby the Buyers sold 100% of their equity interests in Ignite Proteomics, LLC, a Delaware limited liability company (" Ignite ") and formerly a wholly owned subsidiary of IMAC plus $475,000 in cash, for a total consideration of 36,000 shares of the Company's newly created Series A-2 Convertible Preferred Stock (the " Preferred Shares ").”
EQEquillium, Inc.
Equillium, Inc. entered into Securities Purchase Agreement with RA Capital Healthcare Fund, L.P. valued at approximately $35.0 million (effective 2026-03-11).
“On March 11, 2026, Equillium, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with RA Capital Healthcare Fund, L.P. (the “Investor”), pursuant to which the Company agreed to sell and issue shares (“Shares”) of the Company’s common stock, par value $0.0001 (“Common Stock”), and a pre-funded warrant to purchase shares of Common Stock (“Warrant Shares”), in a private placement transaction (the “Private Placement”).”
TRSOTRANSUITE.ORG INC.
TRANSUITE.ORG INC. entered into Cooperation Agreement with Crestar Holdings Limited, Australian Fintech Group Pty Ltd, AEEC INTERNATIONAL PTY LTD valued at 8,000,000 restricted shares of its common stock (effective 2026-03-10).
“On March 10, 2026, Transuite.Org Inc. (the “Company”, Ticker: TRSO) entered into a Cooperation Agreement (the “Agreement”) with Crestar Holdings Limited (“Crestar”), Australian Fintech Group Pty Ltd (“AFT Group”), and AEEC INTERNATIONAL PTY LTD (formerly known as Australian Equity Exchange Center Pty Ltd) (“AEEC”).”
VBIOValion Bio, Inc.
Valion Bio, Inc. entered into Office Sublease with Texas Research and Technology Foundation valued at Monthly base rent starting at $31,044.94 with annual increases of approximately 3.0% (effective 2026-03-13).
“On March 13, 2026, VBI entered into a Sublease (the “Office Sublease” and together with the Microbial Building Lease and the Mammalian Building Lease, the “Facility Leases”) with Texas Research and Technology Foundation (“TRTF”) to sublease approximately 8,122 square feet of office space located at the Property, which Office Sublease was consented to by TPB, as landlord of the leased premises, and is subject to the terms of that certain Office Lease Agreement, dated June 1, 2024, by and between TRTF and TPB.”
VBIOValion Bio, Inc.
Valion Bio, Inc. entered into Mammalian Building Lease with Merchants Ice II, LLC valued at Monthly base rent of $55,029.73 for first twelve months, aggregate base rent over lease term approxi (effective 2026-01-01).
“On March 9, 2026, VBI entered into a Lease (the “Mammalian Building Lease”) with Merchants Ice II, LLC (“Merchants Ice II”) to lease an approximately 20,144 square foot facility located at the Property.”
VBIOValion Bio, Inc.
Valion Bio, Inc. entered into Microbial Building Lease with TPB Merchants Ice LLC valued at Monthly base rent of approximately $22,605 for first twelve months, aggregate base rent over eight-y (effective 2026-03-13).
“On March 13, 2026, Tivic Health Systems, Inc.’s (the “Company”) wholly owned subsidiary Velocity Bioworks, Inc. (“VBI”) entered into a Building Lease Agreement (the “Microbial Building Lease”) with TPB Merchants Ice LLC (“TPB”) to lease an approximately 8,024 square foot facility (the “Microbial Building”) located at 1305 E. Houston St., San Antonio, TX 78205 (the “Property”).”
NXXTNEXTNRG, INC.
NEXTNRG, INC. terminated the Note with the Noteholder valued at $2,000,000 (effective 2026-03-11).
“In connection with entry into the March 11 SPA and payment of the Purchase Price through the Noteholder’s absolving of the Company’s liability in the amount of $1,750,000 pursuant to the Note, the Note was terminated on March 11, 2026.”
NXXTNEXTNRG, INC.
NEXTNRG, INC. entered into Future Receivables Sale and Purchase Agreement with a third party funder (the “Purchaser”) valued at $2,100,000 (effective 2026-03-05).
“On March 9, 2026, the Company entered into a Future Receivables Sale and Purchase Agreement (the “Receivables Agreement”), dated as of March 5, 2026, with a third party funder (the “Purchaser”). Pursuant to the terms of the Receivables Agreement, the Company agreed to sell to the Purchaser, and the Purchaser agreed to purchase, the Company’s right, title and interest in 6.87% (the “Specified Percentage”) of the Company’s receipts of monies for the sale of its goods and services after the effective date of the Agreement (the “Future Receipts”) until $2,772,000 (the “Purchased Amount”) shall have been delivered by the Company to the Purchaser. In consideration thereof, the Purchaser paid $2,100,000 to the Company”
NXXTNEXTNRG, INC.
NEXTNRG, INC. entered into March 11 Stock Purchase Agreement with the Noteholder valued at $1,750,000 (effective 2026-03-11).
“On March 11, 2026, the Company entered into a Stock Purchase Agreement (the “March 11 SPA”) with the Noteholder. Pursuant to the terms of the March 11 SPA, the Company agreed to sell to the Noteholder, and the Noteholder agreed to purchase, 3,181,818 shares of the Company’s common stock at a purchase price of $1,750,000”
Verizon ABS II LLC
Verizon ABS II LLC entered into Series 2026-1 Account Control Agreement with U.S. Bank Trust Company, National Association and U.S. Bank National Association (effective 2026-03-13).
“a Series 2026-1 Account Control Agreement among the Trust, as grantor, U.S. Bank Trust Company, National Association, as secured party, and U.S. Bank National Association, as financial institution”
Verizon ABS II LLC
Verizon ABS II LLC entered into Indenture with U.S. Bank Trust Company, National Association (effective 2026-03-13).
“an Indenture between the Trust, as issuer, and U.S. Bank Trust Company, National Association, as indenture trustee and note paying agent”
MEHAFunctional Brands Inc.
Functional Brands Inc. entered into Security Agreement with Leonite Fund I, LP, Kips Bay Select LP, FirstFire Global Opportunities Fund, LLC and 3i LP.
“In order to secure its obligations under the Notes, the Exchange Agreement and related documents, the Company has granted the Investors a security interest in and lien on substantially all of the assets of the Company.”
MEHAFunctional Brands Inc.
Functional Brands Inc. entered into Notes with Leonite Fund I, LP, Kips Bay Select LP, FirstFire Global Opportunities Fund, LLC and 3i LP valued at $837,800.
“The aggregate consideration paid for the exchange consists of (i) $6,032,160 in stated value of Series C Preferred, (ii) $900,000 in cash, $450,000 payable immediately and $450,000 to be paid upon the earlier of effectiveness of a registration statement covering Common Stock to be issued in connection with a proposed equity line of credit or 90 days after the date of the Exchange Agreement, (iii) $837,800 in principal amount of Notes and (iv) 5,190,171 shares of Common Stock.”
MEHAFunctional Brands Inc.
Functional Brands Inc. entered into Exchange Agreement with Leonite Fund I, LP, Kips Bay Select LP, FirstFire Global Opportunities Fund, LLC and 3i LP valued at aggregate assigned stated value of $8,378,000 (effective 2026-03-09).
“Effective as of March 9, 2026, Functional Brands Inc. (the “Company”) entered into the Exchange Agreement with Leonite Fund I, LP, Kips Bay Select LP, FirstFire Global Opportunities Fund, LLC and 3i LP (collectively, the “Investors”) pursuant to which the Investors agreed to exchange all of the Company’s Series A and Series B Convertible Preferred Stock held by such Investors for a combined consideration package consisting of shares of the Company’s new Series C Convertible Preferred Stock (the “Series C Preferred”), cash, Notes and shares of the Company’s common stock , par value $0.00001 per share (the “Common Stock”).”
Apollo Debt Solutions BDC
Apollo Debt Solutions BDC amended Grouse Second Credit Facility Amendment with Goldman Sachs Bank USA (effective 2026-03-12).
“On March 12, 2026 (the “ Second Amendment Date ”), Grouse Funding LLC (“ Grouse Funding ”), a wholly owned subsidiary of Apollo Debt Solutions BDC, a Delaware statutory trust (the “ Company ”) entered into the Second Amendment (the “ Grouse Second Credit Facility Amendment ”) to its Credit Agreement (the “ Grouse Secured Credit Facility ”), dated as of July 7, 2022, by and among Grouse Funding, as borrower, the Company, as investment manager and as guarantor, the lenders from time to time party thereto, Goldman Sachs Bank USA, as syndication agent and administrative agent, State Street Bank and Trust Company, as collateral custodian and collateral agent, and Virtus Group, LP, as collateral administrator.”
PFSAProfusa, Inc.
Profusa, Inc. terminated Account Control Agreement with Ascent Partners Fund LLC (effective 2026-03-12).
“On March 12, 2026, Ascent Partners Fund LLC (the “Secured Party”) notified the Company of the termination of the Account Control Agreement (the “Control Agreement”), dated as of September 29, 2025, among the Company, as pledgor, the Secured Party, BitGo Prime LLC (the “Delegate”), and BitGo Trust Company, Inc. (the “Custodian”).”
MSAIMultiSensor AI Holdings, Inc.
MultiSensor AI Holdings, Inc. amended Amendment with certain investors (effective 2026-03-12).
“on March 12, 2026, the Company and certain investors party to that certain Securities Purchase Agreement, dated October 24, 2025 (as amended, the “Securities Purchase Agreement”), entered into an amendment to the Securities Purchase Agreement (the “Amendment”) to permit the Offering.”
MSAIMultiSensor AI Holdings, Inc.
MultiSensor AI Holdings, Inc. entered into Sales Agreement with Roth Capital Partners, LLC and H.C. Wainwright & Co., LLC valued at up to $60,000,000 (effective 2026-03-13).
“On March 13, 2026, MultiSensor AI Holdings, Inc., a Delaware corporation (the “Company”) entered into an at market issuance sales agreement (the “Sales Agreement”) with Roth Capital Partners, LLC and H.C. Wainwright & Co., LLC, as sales agents or principals (the “Agents”), under which the Company may offer and sell shares of the Company’s common stock, par value $0.0001 per share, having an aggregate market value of up to $60,000,000 from time to time through the Agents (the “Offering”).”
CBDW1606 CORP.
1606 CORP. entered into Purchase and Sale Agreement with Jefferson Enterprise Energy, LLC valued at $11,168,864 (effective 2026-03-12).
“On March 12, 2026, 1606 Corp., a Nevada corporation (the " Company "), entered into a Purchase and Sale Agreement (the " Agreement ") with Jefferson Enterprise Energy, LLC, a Texas limited liability company (" Seller "), pursuant to which the Company agreed to purchase certain real property located in Angelina County, Texas, including land, improvements, equipment, permits, warranties and related documents (collectively, the " Property "). The total purchase price for the Property is $11,168,864, consisting of (i) $7,000,000 in cash payable at closing and (ii) the Company's assumption of a mechanic's and materialman's lien recorded as Instrument No. 2025-00458298 in the Official Public Records of Angelina County, Texas (the " Sim Agro Lien ").”
SVCOSilvaco Group, Inc.
Silvaco Group, Inc. entered into Open Market Sale Agreement with Jefferies LLC valued at up to $15.0 million (effective 2026-03-13).
“On March 13, 2026, Silvaco Group, Inc. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC, as sales agent (the “Sales Agent”), pursuant to which the Company may offer and sell from time to time, at its option through the Sales Agent, shares of the Company’s common stock, $0.0001 par value per share, having an aggregate offering price of up to $15.0 million”
VGVenture Global, Inc.
Venture Global, Inc. amended Project Facilities with not explicitly named valued at $20.7 billion under the Project Facilities (effective 2026-03-13).
“On March 13, 2026, Venture Global CP2 LNG, LLC (“CP2”), an indirect, wholly-owned subsidiary of Venture Global, Inc. (the “Company”), amended or amended and restated, as applicable, certain of its financing documents, by upsizing (i) the $11.25 billion senior secured first lien construction term loan facility (the “Phase 1 Construction/Term Facility”) by an aggregate amount equal to $7.85 billion (the “Phase 2 Construction/Term Facility”) and (ii) the $850.0 million senior secured first lien working capital revolving loan and letter of credit facility (the “Working Capital Facility” and, together with the Phase 1 Construction/Term Facility and the Phase 2 Construction/Term Facility, the “Project Facilities”) by $750.0 million, resulting in an aggregate amount of $20.7 billion under the Project Facilities”
AGL Private Credit Income Fund
AGL Private Credit Income Fund entered into Amended and Restated Limited Liability Company Agreement for AGL Enhanced PC Income I LLC with Vintage Strategies at Goldman Sachs Alternatives valued at Up to $300 million aggregate investment ($75 million from Company, $225 million from Vintage Strateg (effective 2026-03-09).
“On March 9, 2026, AGL Private Credit Income Fund (the “Company”) and certain vehicles managed by Vintage Strategies at Goldman Sachs Alternatives (“Vintage Strategies”) entered into an amended and restated limited liability company agreement for AGL EPCI I (the “LLC Agreement”), an unconsolidated entity.”
CLMTCalumet, Inc. /DE
Calumet, Inc. /DE entered into Tenth Amendment to the Third Amended and Restated Credit Agreement with the lenders party thereto and Bank of America, N.A., as administrative agent (effective 2026-03-12).
“On March 12, 2026, the Company entered into the Tenth Amendment to the Third Amended and Restated Credit Agreement (the “Tenth Amendment”), which modifies the Third Amended and Restated Credit Agreement, dated as of February 23, 2018, by and among the General Partner, the Partnership, certain of the Company’s subsidiaries party thereto, the lenders party thereto and Bank of America, N.A., as administrative agent, to permit the issuance of, and the incurrence of indebtedness in connection with, the Additional Notes.”
CLMTCalumet, Inc. /DE
Calumet, Inc. /DE entered into Purchase Agreement with BofA Securities, Inc. as representative of the several initial purchasers valued at $150.0 million (effective 2026-03-12).
“On March 12, 2026, Calumet Specialty Products Partners, L.P. (the “Partnership”), Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”), Calumet, Inc. (the “Company”), Calumet GP, LLC (the “General Partner”) and certain subsidiary guarantors named therein (the “Subsidiary Guarantors”) entered into a purchase agreement (the “Purchase Agreement”) with BofA Securities, Inc. as representative of the several initial purchasers named therein (collectively, the “Initial Purchasers”), under which they agreed to sell $150.0 million aggregate principal amount of the Issuers’ 9.75% Senior Notes due 2031 (the “Additional Notes”) in a private placement conducted pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended.”
KRMNKarman Holdings Inc.
Karman Holdings Inc. amended Fourth Amendment with Citibank, N.A., as Administrative Agent and Collateral Agent valued at $100,000,000 (effective 2026-03-09).
“On March 9, 2026, Karman Holdings Inc. (the “Company”) entered into a Fourth Amendment to its Credit Agreement (the “Fourth Amendment"), which amends the Credit Agreement, dated as of April 1, 2025”
CARAVIS BUDGET GROUP, INC.
AVIS BUDGET GROUP, INC. entered into Series 2026-2 Supplement with The Bank of New York Mellon Trust Company, N.A. (effective 2026-03-11).
“the Series 2026-2 Supplement, dated as of the Closing Date, between ABRCF and The Bank of New York Mellon Trust Company, N.A., as trustee and Series 2026-2 Agent (the “Series 2026-2 Supplement”)”
CARAVIS BUDGET GROUP, INC.
AVIS BUDGET GROUP, INC. entered into Series 2026-1 Supplement with The Bank of New York Mellon Trust Company, N.A. (effective 2026-03-11).
“the Series 2026-1 Supplement, dated as of the Closing Date, between ABRCF and The Bank of New York Mellon Trust Company, N.A., as trustee and Series 2026-1 Agent (the “Series 2026-1 Supplement”)”
CLROCLEARONE INC
CLEARONE INC terminated Warrant Repurchase Agreement with CVI Investments, Inc. valued at aggregate purchase price of $22,000 (effective 2026-03-09).
“On March 9, 2026, ClearOne, Inc. (the “Company”) entered into a Warrant Repurchase Agreement (the “Agreement”) with CVI Investments, Inc. (“CVI”), pursuant to which the Company repurchased certain outstanding common stock purchase warrants previously issued to CVI.”
LFUSLITTELFUSE INC /DE
LITTELFUSE INC /DE entered into "Credit Agreement" with each of the banks, financial institutions and other institutional lenders listed on the respective signature pages thereof valued at $800 million senior unsecured revolving credit facility (effective 2026-03-12).
“On March 12, 2026, Littelfuse, Inc., a Delaware corporation (the “Company”), entered into the Credit Agreement as described below. The Credit Agreement provides for an $800 million senior unsecured revolving credit facility”
PRKRPARKERVISION INC
PARKERVISION INC entered into Exchange Agreement with Holders valued at aggregate outstanding principal amount of $675,000 and accrued and unpaid interest of approximately (effective 2026-03-13).
“On March 13, 2026, ParkerVision, Inc., a Florida corporation (the “ Company ”) entered into exchange agreements (each an "Exchange Agreement" and collectively, the "Exchange Agreements") with certain holders (the "Holders") of the Company's outstanding convertible promissory notes (the "Exchange Notes").”
UEICUNIVERSAL ELECTRONICS INC
UNIVERSAL ELECTRONICS INC amended Twelfth Amendment with U.S. Bank National Association (effective 2026-03-11).
“On March 11, 2026, Universal Electronics Inc. (“UEI” or the “Company”) entered into a Twelfth Amendment (the “Twelfth Amendment” to the Second Amended and Restated Credit Agreement, dated as of October 27, 2017 (as amended, “Credit Agreement”), with the lender thereto and U.S. Bank National Association, as administrative agent.”
CRMSalesforce, Inc.
Salesforce, Inc. entered into Five-Year Credit Agreement with the lenders named th (effective 2026-03-11).
“Five-Year Credit Agreement On March 11, 2026, the Company entered into a Five-Year Credit Agreement with the lenders named th”
CRMSalesforce, Inc.
Salesforce, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC, BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc. and Wells Fargo Securities, LLC valued at $3,500,000,000 aggregate principal amount of 4.500% Senior Notes due 2028 (the “2028 Notes”), $4,250 (effective 2026-03-11).
“On March 11, 2026, Salesforce entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc. and Wells Fargo Securities, LLC, on behalf of the several Underwriters listed in Schedule A thereto (the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $3,500,000,000 aggregate principal amount of 4.500% Senior Notes due 2028 (the “2028 Notes”), $4,250,000,000 aggregate principal amount of 4.650% Senior Notes due 2029 (the “2029 Notes”), $3,750,000,000 aggregate principal amount of 4.900% Senior Notes due 2031 (the “2031 Notes”), $2,750,000,000 aggregate principal amount of 5.200% Senior Notes due 2033 (the “2033 Notes”), $4,500,000,000 aggregate principal amount of 5.550% Senior Notes due 2036 (the “2036 Notes”), $1,500,000,000 aggregate principal amount of 6.400% Senior Notes due 2046 (the “2046 Notes”), $3,750,000,000 aggregate princ”
CRMSalesforce, Inc.
Salesforce, Inc. entered into ASR Agreements with Banco Santander, S.A., Bank of America, N.A., Citibank, N.A., JPMorgan Chase Bank, National Association, and Morgan Stanley & Co. LLC valued at $25 billion (effective 2026-03-11).
“On March 11, 2026, Salesforce, Inc. (the “Company” or “Salesforce”) entered into accelerated share repurchase agreements (the “ASR Agreements”) with Banco Santander, S.A., Bank of America, N.A., Citibank, N.A., JPMorgan Chase Bank, National Association, and Morgan Stanley & Co. LLC (collectively, the “ASR Counterparties”). Under the terms of the ASR Agreements, the Company will repurchase an aggregate of $25 billion of the Company’s common stock”
ITGRInteger Holdings Corp
Integer Holdings Corp entered into Cooperation Agreement with Irenic Capital Management LP, Irenic Capital Management GP LLC, Irenic Capital Evergreen Master Fund LP, and Irenic Capital Evergreen Fund GP LLC (collectively, the "Irenic Parties") (effective 2026-03-09).
“On March 9, 2026 (the “Effective Date”), Integer Holdings Corporation (the “Company”) entered into a Cooperation Agreement (the “Cooperation Agreement”) by and among the Company, Irenic Capital Management LP, a Delaware limited partnership, Irenic Capital Management GP LLC, a Delaware limited liability company, Irenic Capital Evergreen Master Fund LP, a Cayman Islands limited partnership, and Irenic Capital Evergreen Fund GP LLC, a Delaware limited liability company (together, the “Irenic Parties”).”
GPNGLOBAL PAYMENTS INC
GLOBAL PAYMENTS INC entered into Supplemental Indenture No. 8 with U.S. Bank Trust Company, National Association valued at $500 million aggregate principal amount of 4.550% Senior Notes due 2028 and $500 million aggregate p (effective 2026-03-12).
“On March 12, 2026, Global Payments Inc. (the “Company”) completed the previously announced public offering (the “Offering”) and issuance of: · $500 million aggregate principal amount of its 4.550% Senior Notes due 2028 (the “2028 Notes”); and · $500 million aggregate principal amount of its 5.400% Senior Notes due 2033 (the “2033 Notes,” and together with the 2028 Notes, the “Notes”).”
AAOIAPPLIED OPTOELECTRONICS, INC.
APPLIED OPTOELECTRONICS, INC. amended Amendment No. 1 to the Equity Distribution Agreement with Raymond James & Associates, Inc. and Needham & Company, LLC valued at $500 million (effective 2026-03-12).
“On March 12, 2026, Applied Optoelectronics, Inc. (the “Company”) entered into Amendment No. 1 to the Equity Distribution Agreement (the “Amendment”) with Raymond James & Associates, Inc. and Needham & Company, LLC (collectively, the “Sales Agents”), amending the Equity Distribution Agreement dated as of February 26, 2026 among the Company and the Sales Agents (the “Original Agreement” and, together with the Amendment, the “Agreement”).”
ITOXIIOT-OXYS, Inc.
IIOT-OXYS, Inc. entered into Securities Purchase Agreement with GHS Investments, LLC valued at up to $88,000 (effective 2026-03-06).
“On March 6, 2026, IIOT-OXYS, Inc., a Nevada corporation (the “ Company ”), entered into a Securities Purchase Agreement (the “ SPA ”) with GHS Investments, LLC (“ GHS ”) for the purchase and sale of up to ninety-seven (97) shares of the Company’s Series D Convertible Preferred Stock (the “ Preferred Stock ”) for an aggregate purchase price of up to $88,000.”
ITC Holdings Corp.
ITC Holdings Corp. entered into ITCMW Bond Purchase Agreement with initial bondholders named in Schedule A valued at $175,000,000 (effective 2026-03-12).
“ITCMW Series O Bonds and the ITCMW Series P Bonds were sold to institutional accredited investors (as defined by Rule 501(a) of the Securities Act) pursuant to a Bond Purchase Agreement, dated March 12, 2026, between ITCMW and the initial bondholders named in Schedule A thereto (the “ITCMW Bond Purchase Agreement”)”
ITC Holdings Corp.
ITC Holdings Corp. entered into ITCT Bond Purchase Agreement with initial bondholders named in Schedule A valued at $175,000,000 (effective 2026-03-12).
“ITCT Series M Bonds and the ITCT Series N Bonds were sold to institutional accredited investors (as defined by Rule 501(a) of the Securities Act) pursuant to a Bond Purchase Agreement, dated March 12, 2026, between ITC Transmission and the initial bondholders named in Schedule A thereto (the “ITCT Bond Purchase Agreement”)”
IGCIGC Pharma, Inc.
IGC Pharma, Inc. entered into a credit facility with One Deck Capital, Inc. valued at approximately $219,000.
“The Company entered into a loan agreement with One Deck Capital, Inc. (“One Deck”), pursuant to which the Company received approximately $219,000 in financing (the “One Deck Loan”).”
IGCIGC Pharma, Inc.
IGC Pharma, Inc. entered into Promissory Note with Vanquish Funding Group Inc. valued at $353,050 (effective 2026-03-05).
“Pursuant to the terms of the Purchase Agreement, the Company issued a Promissory Note (the “Note”) to VFG with a total principal amount of $353,050”
IGCIGC Pharma, Inc.
IGC Pharma, Inc. entered into Securities Purchase Agreement with Vanquish Funding Group Inc. (effective 2026-03-05).
“On March 5, 2026, IGC Pharma, Inc. (“IGC” or the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Vanquish Funding Group Inc., a Virginia corporation (“VFG” or the “Holder”).”
BCICBCP Investment Corp
BCP Investment Corp amended Third Amendment with Great Lakes Portman Ridge Funding LLC valued at $125,000,000 (effective 2026-03-09).
“On March 9, 2026, Great Lakes Portman Ridge Funding LLC (“SPV”), a wholly-owned subsidiary of BCP Investment Corporation (the “Company”), entered into a third amendment (the “Third Amendment”) to its senior secured revolving credit facility dated December 18, 2019”
QRHCQuest Resource Holding Corp
Quest Resource Holding Corp terminated Loan, Security and Guaranty Agreement with PNC Bank, National Association (effective 2026-03-12).
“On March 12, 2026, contemporaneously with the execution and delivery of the TCB Loan Agreement, that certain Loan, Security and Guaranty Agreement, dated as of August 5, 2020, as amended, with PNC Bank, National Association, successor to BBVA USA, as a lender, and as administrative agent, collateral agent, and issuing bank, was terminated in accordance with its terms thereof and all outstanding amounts thereunder were repaid.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.